VNDA logo

VNDA
Vanda Pharmaceuticals Inc

5,508
Mkt Cap
$413.76M
Volume
920,013.00
52W High
$9.94
52W Low
$3.81
PE Ratio
-1.87
VNDA Fundamentals
Price
$7.00
Prev Close
$7.07
Open
$6.84
50D MA
$7.68
Beta
0.76
Avg. Volume
2.09M
EPS (Annual)
-$3.74
P/B
1.26
Rev/Employee
$405,450.28
$268.44
Loading...
Loading...
News
all
press releases
Vanda Pharmaceuticals (NASDAQ:VNDA) Share Price Passes Above 200-Day Moving Average - Here's Why
Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Pass Above 200 Day Moving Average - Here's Why...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods
Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from...
PR Newswire·17d ago
News Placeholder
Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Gap Up - Time to Buy?
Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Gap Up - Here's Why...
MarketBeat·19d ago
News Placeholder
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Sees Significant Growth in Short Interest
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) was the recipient of a large increase in short interest in February. As of February 27th, there was short interest totaling 4,346,005...
MarketBeat·22d ago
News Placeholder
Vanda Pharmaceuticals (NASDAQ:VNDA) Sets New 52-Week High - What's Next?
Vanda Pharmaceuticals (NASDAQ:VNDA) Sets New 12-Month High - What's Next...
MarketBeat·27d ago
News Placeholder
Vanda Pharmaceuticals (NASDAQ:VNDA) Trading Up 8.1% - Should You Buy?
Vanda Pharmaceuticals (NASDAQ:VNDA) Trading Up 8.1% - Still a Buy...
MarketBeat·27d ago
News Placeholder
Truist Financial Begins Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)
Truist Financial initiated coverage on Vanda Pharmaceuticals in a report on Thursday. They set a "buy" rating and a $18.00 price target on the stock...
MarketBeat·1mo ago
News Placeholder
Vanda Pharmaceuticals (NASDAQ:VNDA) CMO Joakim Wijkstrom Sells 30,800 Shares
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) CMO Joakim Wijkstrom sold 30,800 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...
MarketBeat·1mo ago
News Placeholder
Gunther Birznieks Sells 42,431 Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) Stock
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) SVP Gunther Birznieks sold 42,431 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Insider Selling: Vanda Pharmaceuticals (NASDAQ:VNDA) SVP Sells 42,434 Shares of Stock
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) SVP Timothy Williams sold 42,434 shares of the business's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...
MarketBeat·1mo ago
<
1
2
...
>

Latest VNDA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.